nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—parathyroid gland—thyroid cancer	0.227	0.452	CbGeAlD
Amifostine—ALPPL2—neck—thyroid cancer	0.0688	0.137	CbGeAlD
Amifostine—Blood calcium decreased—Vandetanib—thyroid cancer	0.062	0.137	CcSEcCtD
Amifostine—ALPL—thyroid gland—thyroid cancer	0.037	0.0736	CbGeAlD
Amifostine—ENPP1—thyroid gland—thyroid cancer	0.034	0.0676	CbGeAlD
Amifostine—ALPPL2—thyroid gland—thyroid cancer	0.0328	0.0651	CbGeAlD
Amifostine—Respiratory arrest—Vandetanib—thyroid cancer	0.032	0.0709	CcSEcCtD
Amifostine—ENPP1—head—thyroid cancer	0.0302	0.0599	CbGeAlD
Amifostine—ALPPL2—head—thyroid cancer	0.0291	0.0578	CbGeAlD
Amifostine—ALPL—lymph node—thyroid cancer	0.023	0.0457	CbGeAlD
Amifostine—ENPP1—lymph node—thyroid cancer	0.0211	0.042	CbGeAlD
Amifostine—Hypocalcaemia—Vandetanib—thyroid cancer	0.0154	0.0341	CcSEcCtD
Amifostine—Myocardial ischaemia—Sorafenib—thyroid cancer	0.0118	0.0262	CcSEcCtD
Amifostine—Atrial fibrillation—Vandetanib—thyroid cancer	0.0108	0.0239	CcSEcCtD
Amifostine—Hypocalcaemia—Sorafenib—thyroid cancer	0.0104	0.023	CcSEcCtD
Amifostine—Cardiac arrest—Vandetanib—thyroid cancer	0.00972	0.0215	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00781	0.0173	CcSEcCtD
Amifostine—Renal failure—Vandetanib—thyroid cancer	0.00774	0.0172	CcSEcCtD
Amifostine—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00731	0.0162	CcSEcCtD
Amifostine—Bradycardia—Vandetanib—thyroid cancer	0.0072	0.0159	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—LGALS3—thyroid cancer	0.00712	0.157	CbGpPWpGaD
Amifostine—Erythema multiforme—Vandetanib—thyroid cancer	0.00669	0.0148	CcSEcCtD
Amifostine—Arrhythmia—Vandetanib—thyroid cancer	0.00632	0.014	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—PTCH1—thyroid cancer	0.00626	0.138	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00621	0.0138	CcSEcCtD
Amifostine—Loss of consciousness—Vandetanib—thyroid cancer	0.00541	0.012	CcSEcCtD
Amifostine—Convulsion—Vandetanib—thyroid cancer	0.00533	0.0118	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—PTCH1—thyroid cancer	0.00532	0.117	CbGpPWpGaD
Amifostine—Hypertension—Vandetanib—thyroid cancer	0.00532	0.0118	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00527	0.0117	CcSEcCtD
Amifostine—Chest pain—Vandetanib—thyroid cancer	0.00524	0.0116	CcSEcCtD
Amifostine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00524	0.0116	CcSEcCtD
Amifostine—Renal failure—Sorafenib—thyroid cancer	0.00522	0.0116	CcSEcCtD
Amifostine—Myocardial infarction—Sorafenib—thyroid cancer	0.00521	0.0115	CcSEcCtD
Amifostine—Erythema multiforme—Sorafenib—thyroid cancer	0.00451	0.00999	CcSEcCtD
Amifostine—Dyspnoea—Vandetanib—thyroid cancer	0.00448	0.00992	CcSEcCtD
Amifostine—Feeling hot—Epirubicin—thyroid cancer	0.00447	0.00991	CcSEcCtD
Amifostine—Flushing—Sorafenib—thyroid cancer	0.00443	0.00981	CcSEcCtD
Amifostine—Rigors—Epirubicin—thyroid cancer	0.0043	0.00953	CcSEcCtD
Amifostine—Arrhythmia—Sorafenib—thyroid cancer	0.00426	0.00944	CcSEcCtD
Amifostine—Feeling hot—Doxorubicin—thyroid cancer	0.00414	0.00917	CcSEcCtD
Amifostine—Rigors—Doxorubicin—thyroid cancer	0.00398	0.00881	CcSEcCtD
Amifostine—Body temperature increased—Vandetanib—thyroid cancer	0.00397	0.0088	CcSEcCtD
Amifostine—Hypocalcaemia—Epirubicin—thyroid cancer	0.00384	0.00849	CcSEcCtD
Amifostine—Syncope—Sorafenib—thyroid cancer	0.00372	0.00825	CcSEcCtD
Amifostine—Loss of consciousness—Sorafenib—thyroid cancer	0.00365	0.00808	CcSEcCtD
Amifostine—Hypertension—Sorafenib—thyroid cancer	0.00359	0.00794	CcSEcCtD
Amifostine—Pruritus—Vandetanib—thyroid cancer	0.00356	0.00787	CcSEcCtD
Amifostine—Hypocalcaemia—Doxorubicin—thyroid cancer	0.00355	0.00786	CcSEcCtD
Amifostine—Hiccups—Epirubicin—thyroid cancer	0.00351	0.00778	CcSEcCtD
Amifostine—Anaphylactic shock—Sorafenib—thyroid cancer	0.00339	0.00751	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—HIF1A—thyroid cancer	0.00335	0.0738	CbGpPWpGaD
Amifostine—Shock—Sorafenib—thyroid cancer	0.00333	0.00739	CcSEcCtD
Amifostine—Dizziness—Vandetanib—thyroid cancer	0.00332	0.00736	CcSEcCtD
Amifostine—Hiccups—Doxorubicin—thyroid cancer	0.00325	0.0072	CcSEcCtD
Amifostine—Vomiting—Vandetanib—thyroid cancer	0.00319	0.00708	CcSEcCtD
Amifostine—Rash—Vandetanib—thyroid cancer	0.00317	0.00702	CcSEcCtD
Amifostine—Dermatitis—Vandetanib—thyroid cancer	0.00317	0.00701	CcSEcCtD
Amifostine—Dyspnoea—Sorafenib—thyroid cancer	0.00302	0.00669	CcSEcCtD
Amifostine—Nausea—Vandetanib—thyroid cancer	0.00298	0.00661	CcSEcCtD
Amifostine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.0027	0.00598	CcSEcCtD
Amifostine—Urticaria—Sorafenib—thyroid cancer	0.00269	0.00596	CcSEcCtD
Amifostine—Body temperature increased—Sorafenib—thyroid cancer	0.00268	0.00593	CcSEcCtD
Amifostine—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00263	0.00583	CcSEcCtD
Amifostine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.0025	0.00554	CcSEcCtD
Amifostine—Hypersensitivity—Sorafenib—thyroid cancer	0.0025	0.00553	CcSEcCtD
Amifostine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00244	0.0054	CcSEcCtD
Amifostine—Cardiac arrest—Epirubicin—thyroid cancer	0.00242	0.00537	CcSEcCtD
Amifostine—Pruritus—Sorafenib—thyroid cancer	0.0024	0.00531	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.0023	0.00508	CcSEcCtD
Amifostine—Cardiac arrest—Doxorubicin—thyroid cancer	0.00224	0.00497	CcSEcCtD
Amifostine—Dizziness—Sorafenib—thyroid cancer	0.00224	0.00496	CcSEcCtD
Amifostine—Vomiting—Sorafenib—thyroid cancer	0.00216	0.00477	CcSEcCtD
Amifostine—Rash—Sorafenib—thyroid cancer	0.00214	0.00473	CcSEcCtD
Amifostine—Dermatitis—Sorafenib—thyroid cancer	0.00214	0.00473	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00212	0.0047	CcSEcCtD
Amifostine—Nausea—Sorafenib—thyroid cancer	0.00201	0.00446	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00195	0.00431	CcSEcCtD
Amifostine—Renal failure—Epirubicin—thyroid cancer	0.00193	0.00428	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.0018	0.00399	CcSEcCtD
Amifostine—Bradycardia—Epirubicin—thyroid cancer	0.0018	0.00398	CcSEcCtD
Amifostine—Renal failure—Doxorubicin—thyroid cancer	0.00179	0.00396	CcSEcCtD
Amifostine—Erythema multiforme—Epirubicin—thyroid cancer	0.00167	0.00369	CcSEcCtD
Amifostine—Bradycardia—Doxorubicin—thyroid cancer	0.00166	0.00368	CcSEcCtD
Amifostine—Flushing—Epirubicin—thyroid cancer	0.00164	0.00362	CcSEcCtD
Amifostine—Chills—Epirubicin—thyroid cancer	0.00158	0.0035	CcSEcCtD
Amifostine—Arrhythmia—Epirubicin—thyroid cancer	0.00158	0.00349	CcSEcCtD
Amifostine—Erythema multiforme—Doxorubicin—thyroid cancer	0.00154	0.00342	CcSEcCtD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	0.00153	0.0337	CbGpPWpGaD
Amifostine—Flushing—Doxorubicin—thyroid cancer	0.00151	0.00335	CcSEcCtD
Amifostine—Chills—Doxorubicin—thyroid cancer	0.00146	0.00324	CcSEcCtD
Amifostine—Arrhythmia—Doxorubicin—thyroid cancer	0.00146	0.00323	CcSEcCtD
Amifostine—Ill-defined disorder—Epirubicin—thyroid cancer	0.00142	0.00315	CcSEcCtD
Amifostine—Malaise—Epirubicin—thyroid cancer	0.00138	0.00307	CcSEcCtD
Amifostine—Syncope—Epirubicin—thyroid cancer	0.00138	0.00305	CcSEcCtD
Amifostine—Loss of consciousness—Epirubicin—thyroid cancer	0.00135	0.00299	CcSEcCtD
Amifostine—ENPP1—Disease—TRIM24—thyroid cancer	0.00133	0.0293	CbGpPWpGaD
Amifostine—Convulsion—Epirubicin—thyroid cancer	0.00133	0.00295	CcSEcCtD
Amifostine—Hypertension—Epirubicin—thyroid cancer	0.00133	0.00294	CcSEcCtD
Amifostine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00132	0.00292	CcSEcCtD
Amifostine—ENPP1—Metabolism—MINPP1—thyroid cancer	0.00131	0.0289	CbGpPWpGaD
Amifostine—Chest pain—Epirubicin—thyroid cancer	0.00131	0.00289	CcSEcCtD
Amifostine—Discomfort—Epirubicin—thyroid cancer	0.00129	0.00286	CcSEcCtD
Amifostine—Malaise—Doxorubicin—thyroid cancer	0.00128	0.00284	CcSEcCtD
Amifostine—Syncope—Doxorubicin—thyroid cancer	0.00127	0.00282	CcSEcCtD
Amifostine—Anaphylactic shock—Epirubicin—thyroid cancer	0.00125	0.00277	CcSEcCtD
Amifostine—ENPP1—Disease—CHST14—thyroid cancer	0.00125	0.0275	CbGpPWpGaD
Amifostine—Loss of consciousness—Doxorubicin—thyroid cancer	0.00125	0.00276	CcSEcCtD
Amifostine—Shock—Epirubicin—thyroid cancer	0.00123	0.00273	CcSEcCtD
Amifostine—Convulsion—Doxorubicin—thyroid cancer	0.00123	0.00273	CcSEcCtD
Amifostine—Hypertension—Doxorubicin—thyroid cancer	0.00123	0.00272	CcSEcCtD
Amifostine—Tachycardia—Epirubicin—thyroid cancer	0.00122	0.00271	CcSEcCtD
Amifostine—Chest pain—Doxorubicin—thyroid cancer	0.00121	0.00268	CcSEcCtD
Amifostine—Discomfort—Doxorubicin—thyroid cancer	0.00119	0.00265	CcSEcCtD
Amifostine—ENPP1—Disease—TRIM33—thyroid cancer	0.00119	0.0261	CbGpPWpGaD
Amifostine—Hypotension—Epirubicin—thyroid cancer	0.00117	0.00259	CcSEcCtD
Amifostine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00116	0.00257	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—AKT1—thyroid cancer	0.00116	0.0254	CbGpPWpGaD
Amifostine—Shock—Doxorubicin—thyroid cancer	0.00114	0.00253	CcSEcCtD
Amifostine—Tachycardia—Doxorubicin—thyroid cancer	0.00113	0.00251	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—AKT1—thyroid cancer	0.00113	0.0248	CbGpPWpGaD
Amifostine—Dyspnoea—Epirubicin—thyroid cancer	0.00112	0.00247	CcSEcCtD
Amifostine—ENPP1—Metabolism—NDUFA13—thyroid cancer	0.00112	0.0245	CbGpPWpGaD
Amifostine—Somnolence—Epirubicin—thyroid cancer	0.00111	0.00247	CcSEcCtD
Amifostine—Hypotension—Doxorubicin—thyroid cancer	0.00108	0.0024	CcSEcCtD
Amifostine—ENPP1—Metabolism—CHST14—thyroid cancer	0.00105	0.0231	CbGpPWpGaD
Amifostine—Dyspnoea—Doxorubicin—thyroid cancer	0.00103	0.00229	CcSEcCtD
Amifostine—Feeling abnormal—Epirubicin—thyroid cancer	0.00103	0.00229	CcSEcCtD
Amifostine—Somnolence—Doxorubicin—thyroid cancer	0.00103	0.00228	CcSEcCtD
Amifostine—Urticaria—Epirubicin—thyroid cancer	0.000995	0.0022	CcSEcCtD
Amifostine—Body temperature increased—Epirubicin—thyroid cancer	0.00099	0.00219	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—AKT1—thyroid cancer	0.000983	0.0216	CbGpPWpGaD
Amifostine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000955	0.00212	CcSEcCtD
Amifostine—Hypersensitivity—Epirubicin—thyroid cancer	0.000923	0.00204	CcSEcCtD
Amifostine—Urticaria—Doxorubicin—thyroid cancer	0.000921	0.00204	CcSEcCtD
Amifostine—Body temperature increased—Doxorubicin—thyroid cancer	0.000916	0.00203	CcSEcCtD
Amifostine—Pruritus—Epirubicin—thyroid cancer	0.000886	0.00196	CcSEcCtD
Amifostine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000854	0.00189	CcSEcCtD
Amifostine—ENPP1—Metabolism—HPGD—thyroid cancer	0.000845	0.0186	CbGpPWpGaD
Amifostine—Dizziness—Epirubicin—thyroid cancer	0.000828	0.00183	CcSEcCtD
Amifostine—Pruritus—Doxorubicin—thyroid cancer	0.00082	0.00182	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PTEN—thyroid cancer	0.000819	0.018	CbGpPWpGaD
Amifostine—Vomiting—Epirubicin—thyroid cancer	0.000796	0.00176	CcSEcCtD
Amifostine—ENPP1—Disease—TCF7L1—thyroid cancer	0.000792	0.0174	CbGpPWpGaD
Amifostine—Rash—Epirubicin—thyroid cancer	0.00079	0.00175	CcSEcCtD
Amifostine—Dermatitis—Epirubicin—thyroid cancer	0.000789	0.00175	CcSEcCtD
Amifostine—Dizziness—Doxorubicin—thyroid cancer	0.000766	0.0017	CcSEcCtD
Amifostine—Nausea—Epirubicin—thyroid cancer	0.000744	0.00165	CcSEcCtD
Amifostine—Vomiting—Doxorubicin—thyroid cancer	0.000737	0.00163	CcSEcCtD
Amifostine—Rash—Doxorubicin—thyroid cancer	0.000731	0.00162	CcSEcCtD
Amifostine—Dermatitis—Doxorubicin—thyroid cancer	0.00073	0.00162	CcSEcCtD
Amifostine—Nausea—Doxorubicin—thyroid cancer	0.000688	0.00152	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—HRAS—thyroid cancer	0.000684	0.0151	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—AKT1—thyroid cancer	0.000604	0.0133	CbGpPWpGaD
Amifostine—ENPP1—Disease—TPR—thyroid cancer	0.00058	0.0128	CbGpPWpGaD
Amifostine—ENPP1—Disease—PRKAR1A—thyroid cancer	0.00057	0.0125	CbGpPWpGaD
Amifostine—ENPP1—Disease—MEN1—thyroid cancer	0.000545	0.012	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—HRAS—thyroid cancer	0.000535	0.0118	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—TPR—thyroid cancer	0.000485	0.0107	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PRKAR1A—thyroid cancer	0.000478	0.0105	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—AKT1—thyroid cancer	0.000472	0.0104	CbGpPWpGaD
Amifostine—ENPP1—Disease—CALCA—thyroid cancer	0.000434	0.00955	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDK1—thyroid cancer	0.000393	0.00864	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC5A5—thyroid cancer	0.000363	0.008	CbGpPWpGaD
Amifostine—ENPP1—Disease—NRG1—thyroid cancer	0.000315	0.00694	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—RXRA—thyroid cancer	0.000305	0.00672	CbGpPWpGaD
Amifostine—ENPP1—Disease—TERT—thyroid cancer	0.000283	0.00623	CbGpPWpGaD
Amifostine—ENPP1—Disease—HIF1A—thyroid cancer	0.000271	0.00596	CbGpPWpGaD
Amifostine—ENPP1—Disease—BRAF—thyroid cancer	0.000224	0.00493	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PPARG—thyroid cancer	0.000193	0.00424	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTGS2—thyroid cancer	0.000181	0.00398	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTEN—thyroid cancer	0.000158	0.00347	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTGS2—thyroid cancer	0.000152	0.00334	CbGpPWpGaD
Amifostine—ENPP1—Disease—NRAS—thyroid cancer	0.000141	0.0031	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTEN—thyroid cancer	0.000132	0.00291	CbGpPWpGaD
Amifostine—ENPP1—Disease—KRAS—thyroid cancer	0.000121	0.00267	CbGpPWpGaD
Amifostine—ENPP1—Disease—HRAS—thyroid cancer	0.000103	0.00227	CbGpPWpGaD
Amifostine—ENPP1—Disease—AKT1—thyroid cancer	9.1e-05	0.002	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AKT1—thyroid cancer	7.62e-05	0.00168	CbGpPWpGaD
